Johnson Matthey completes sale of its Diagnostic Services business

Johnson Matthey

Johnson Matthey Plc (LON:JMAT), has announced that, further to the announcement on 3rd May 2023, it has completed the sale of its Diagnostic Services business on 29th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers’ products. 

Share on:

Latest Company News

Johnson Matthey updates Honeywell deal timeline and financial terms

Johnson Matthey Plc and Honeywell have agreed to extend the completion timeline for the Catalyst Technologies transaction to July...

Johnson Matthey issues pre-close update and reclassifies Catalyst Technologies

Johnson Matthey has confirmed that Catalyst Technologies, following its agreed sale to Honeywell, will be reported as a discontinued...

Johnson Matthey appoints Richard Pike as Chief Financial Officer Designate

Johnson Matthey plc appoints Richard Pike as Chief Financial Officer Designate, effective immediately, ensuring a smooth transition before April...

Johnson Matthey Plc hosting PGM Services seminar for investors and analysts today

Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net...

Johnson Matthey Plc to sell Medical Device Components business for $700 million

Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity...

    Search